Inactive Instrument

News Nuvo Pharmaceuticals Inc Toronto S.E.

Equities

CA67092F1045

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Nuvo Pharmaceuticals : Miravo Healthcare ranks on The Globe and Mail’s fourth-annual Women Lead Here benchmark of executive gender diversity	23-03-24	PU
Searchlight Pharma Inc. completed the acquisition of Nuvo Pharmaceuticals Inc. from Red Oak Partners, LLC and other shareholders.	23-03-13	CI
Miravo Healthcare Obtains Final Order Approving Plan of Arrangement	23-03-13	AQ
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare Brief: Obtained Friday Final Order Approving Plan of Arrangement Related To Acquisition by Searchlight Pharma Inc.	23-03-13	MT
Miravo Healthcare Announces Shareholder Approval of Plan of Arrangement	23-03-08	AQ
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare Brief: Announcing Shareholder Approval of Plan of Arrangement Related To Acquisition by Searchlight Pharma Inc.	23-03-07	MT
Miravo Healthcare Special Meeting Reminder	23-02-22	AQ
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare Up 88% After Entering into Definitive Agreement to be Acquired by Searchlight Pharma Inc.	22-12-28	MT
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare Entered into Definitive Agreement to be Acquired by Searchlight Pharma Inc.	22-12-28	MT
Searchlight Pharma Inc. entered into a definitive agreement to acquire Nuvo Pharmaceuticals Inc. from Red Oak Partners, LLC and other shareholders for CAD 15.4 million.	22-12-22	CI
Nuvo Pharmaceuticals Inc. - Miravo Healthcare Announces Third Quarter 2022 Results	22-11-15	AQ
Transcript : Nuvo Pharmaceuticals Inc., Q3 2022 Earnings Call, Nov 14, 2022	22-11-14
Nuvo: Q3 Earnings Snapshot	22-11-14	AQ
Miravo Healthcare Reports Q3 Results, Says Canadian Commercial Business Segment Continues to Grow	22-11-14	MT
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Earnings Flash (MRV) NUVO PHARMACEUTICALS Reports Q3 Revenue $18.1M	22-11-14	MT
Nuvo Pharmaceuticals Inc. - Miravo Healthcare Announces Third Quarter 2022 Results Release Date and Conference Call Details	22-11-01	AQ
Nuvo Pharmaceuticals : Supplemental Information	22-08-26	PU
Miravo Healthcare Announces Appointment of Anthony Snow to its Board of Directors	22-08-17	AQ
Miravo Healthcare Announces Second Quarter 2022 Results	22-08-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nuvo Pharmaceuticals Inc Toronto S.E.

Equities

CA67092F1045

Summary

Filters